This Blanket Purchase Agreement (BPA) contract with a ceiling value of $978,250.00 was awarded by the U.S. Department of Veterans Affairs (VA) to Pharmalogic Holdings Corp. (doing business as Pharmalogic Puerto Rico), a for-profit corporate entity. The contract is for the supply of F18-Florbetapir (NeuraCeq) radiopharmaceutical unit doses to support nuclear medicine diagnostic imaging procedures at VA medical facilities.
The contract is a single-award BPA structured as a delivery order with a performance period from March 15, 2025 to March 14, 2030. It was set aside for small businesses under NAICS code 325413 (In-Vitro Diagnostic Substance Manufacturing). The contract requires the delivery of radiopharmaceutical doses that comply with federal regulations for medical byproducts, with specific requirements for delivery timing, documentation, and quality control. The increasing annual quantities, from 40 doses in the first year to 100 doses in the fifth year, suggest potential budget flexibility to meet evolving VA medical imaging needs for veterans.
Generated 3/15/25, 9:49 AM